These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 1526654

  • 1. Differential effects of a murine and chimeric mouse/human anti-interleukin-2 receptor antibody on human T-cell proliferation.
    Rose B, Gillespie A, Wunderlich D, Kelley K, Dzuiba J, Shedd D, Cahill K, Zerler B.
    Immunology; 1992 Jul; 76(3):452-9. PubMed ID: 1526654
    [Abstract] [Full Text] [Related]

  • 2. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
    Coney LR, Mezzanzanica D, Sanborn D, Casalini P, Colnaghi MI, Zurawski VR.
    Cancer Res; 1994 May 01; 54(9):2448-55. PubMed ID: 7512887
    [Abstract] [Full Text] [Related]

  • 3. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K, Koike M, Shitara K, Kuwana Y, Kiuragi K, Igarashi S, Hasegawa M, Hanai N.
    Cancer Res; 1994 Mar 15; 54(6):1511-6. PubMed ID: 8137257
    [Abstract] [Full Text] [Related]

  • 4. IL-2-dependent proliferation of murine T cells requires expression of both the p55 and p70 subunits of the IL-2 receptor.
    Jankovic DL, Rebollo A, Kumar A, Gibert M, Thèze J.
    J Immunol; 1990 Dec 15; 145(12):4136-44. PubMed ID: 2258612
    [Abstract] [Full Text] [Related]

  • 5. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
    Alvarez-Rueda N, Leprieur S, Clémenceau B, Supiot S, Sébille-Rivain V, Faivre-Chauvet A, Davodeau F, Paris F, Barbet J, Aubry J, Birklé S.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
    [Abstract] [Full Text] [Related]

  • 6. A chimeric mouse/human anti-IL-2 receptor antibody with enhanced biological activities.
    Rose B, Gillespie A, Wunderlich D, Barbosa JA, Cahill K, Dzuiba J, Shedd D, Zerler B.
    Mol Immunol; 1992 Jan 15; 29(1):131-44. PubMed ID: 1731187
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a human T cell-specific chimeric antibody (CD7) with human constant and mouse variable regions.
    Heinrich G, Gram H, Kocher HP, Schreier MH, Ryffel B, Akbar A, Amlot PL, Janossy G.
    J Immunol; 1989 Dec 01; 143(11):3589-97. PubMed ID: 2479683
    [Abstract] [Full Text] [Related]

  • 8. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
    Shibaguchi H, Arakawa F, Imakiire T, Kuroki M, Kuroki M.
    Anticancer Res; 2003 Dec 01; 23(6a):4383-8. PubMed ID: 14666725
    [Abstract] [Full Text] [Related]

  • 9. Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression.
    Woodle ES, Thistlethwaite JR, Jolliffe LK, Zivin RA, Collins A, Adair JR, Bodmer M, Athwal D, Alegre ML, Bluestone JA.
    J Immunol; 1992 May 01; 148(9):2756-63. PubMed ID: 1533410
    [Abstract] [Full Text] [Related]

  • 10. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
    Sahagan BG, Dorai H, Saltzgaber-Muller J, Toneguzzo F, Guindon CA, Lilly SP, McDonald KW, Morrissey DV, Stone BA, Davis GL.
    J Immunol; 1986 Aug 01; 137(3):1066-74. PubMed ID: 3088107
    [Abstract] [Full Text] [Related]

  • 11. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.
    Cancer Res; 2000 Dec 15; 60(24):6977-84. PubMed ID: 11156399
    [Abstract] [Full Text] [Related]

  • 12. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
    Mount PF, Sutton VR, Li W, Burgess J, McKEnzie IF, Pietersz GA, Trapani JA.
    Cancer Res; 1994 Dec 01; 54(23):6160-6. PubMed ID: 7954462
    [Abstract] [Full Text] [Related]

  • 13. Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen.
    Beidler CB, Ludwig JR, Cardenas J, Phelps J, Papworth CG, Melcher E, Sierzega M, Myers LJ, Unger BW, Fisher M.
    J Immunol; 1988 Dec 01; 141(11):4053-60. PubMed ID: 3141512
    [Abstract] [Full Text] [Related]

  • 14. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
    Liao SK, Horton L, Flahart RE, O'Rear L, Crumpacker D, Imbaratto JW, Yannelli JR, Robinson RR, Oldham RK.
    Hum Antibodies Hybridomas; 1990 Dec 01; 1(2):66-76. PubMed ID: 2103354
    [Abstract] [Full Text] [Related]

  • 15. Construction and characterization of a high-affinity chimeric anti-colorectal carcinoma antibody ccM4.
    Xiang J, Moyana T, Kalra J, Hamilton T, Qi Y.
    Mol Biother; 1992 Dec 01; 4(4):174-83. PubMed ID: 1476671
    [Abstract] [Full Text] [Related]

  • 16. Development and functional characterization of a murine/human chimeric antibody with specificity for the human interleukin-2 receptor.
    Vandevyver C, Steukers M, Lambrechts J, Heyligen H, Raus J.
    Mol Immunol; 1993 Jul 01; 30(10):865-76. PubMed ID: 8341281
    [Abstract] [Full Text] [Related]

  • 17. Selective expansion of genetically modified T cells using an antibody/interleukin-2 receptor chimera.
    Sogo T, Kawahara M, Tsumoto K, Kumagai I, Ueda H, Nagamune T.
    J Immunol Methods; 2008 Aug 20; 337(1):16-23. PubMed ID: 18589435
    [Abstract] [Full Text] [Related]

  • 18. Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18.
    Mouzaki A, Volk HD, Osawa H, Diamantstein T.
    Eur J Immunol; 1987 Mar 20; 17(3):335-41. PubMed ID: 3106058
    [Abstract] [Full Text] [Related]

  • 19. Humanized Mik beta 1, a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC.
    Hakimi J, Ha VC, Lin P, Campbell E, Gately MK, Tsudo M, Payne PW, Waldmann TA, Grant AJ, Tsien WH.
    J Immunol; 1993 Jul 15; 151(2):1075-85. PubMed ID: 8335891
    [Abstract] [Full Text] [Related]

  • 20. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3).
    Demanet C, Brissinck J, Van Mechelen M, Leo O, Thielemans K.
    J Immunol; 1991 Aug 01; 147(3):1091-7. PubMed ID: 1830596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.